Zynerba Pharma CS (ZYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZYNE | SLGL | MGX | ||
| Company | Zynerba Pharma CS | Sol-Gel Technologies Ltd | Metagenomi Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.2600 | 83.00 | 1.4600 | ||
| High | 1.3400 | 84.78 | 1.5400 | ||
| Low | 1.2600 | 78.24 | 1.4406 | ||
| Latest | 1.3000 | 80.85 | 1.5200 | ||
| Change | +0.0300 | -0.16 | +0.0500 | ||
| % Change | +2.36% | -0.20% | +3.40% | ||
| Volume | 862,700 | 13,200 | 249,400 | ||
| 20-Day Average Volume | 1,093,995 | 30,375 | 267,935 | ||
| Previous Close | 1.2700 | 81.01 | 1.4700 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.3012 | 66.16 | 1.5450 | ||
| 20-Day Raw Stochastic | 53.49% | 89.24% | 31.71% | ||
| 20-Day Relative Strength | 62.80 | 67.69 | 44.33 | ||
| Weighted Alpha | -35.90 | +652.04 | -41.02 | ||
| Today's Opinion | 80% Buy | 100% Buy | 88% Sell | ||
| Previous Opinion | 80% Buy | 100% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.17% since 10/03/23 | +22.31% since 02/11/26 | unch since 02/11/26 | ||
| Low | 1.1850 on 10/04/23 | 62.08 on 02/13/26 | 1.4200 on 02/17/26 | ||
| High | 1.3400 on 10/10/23 | 84.78 on 02/19/26 | 1.5400 on 02/19/26 | ||
| 1-Month | |||||
| %Chg | -1.52% since 09/08/23 | +16.33% since 01/16/26 | -8.43% since 01/16/26 | ||
| Low | 1.1850 on 10/04/23 | 48.26 on 01/23/26 | 1.3900 on 02/06/26 | ||
| High | 1.4000 on 09/15/23 | 84.78 on 02/19/26 | 1.8000 on 01/23/26 | ||
| 3-Month | |||||
| %Chg | +293.70% since 07/10/23 | +124.33% since 11/19/25 | -5.59% since 11/19/25 | ||
| Low | 0.2500 on 07/11/23 | 34.10 on 11/20/25 | 1.3900 on 02/06/26 | ||
| High | 1.4000 on 09/15/23 | 84.78 on 02/19/26 | 1.8700 on 12/22/25 | ||
| 6-Month | |||||
| %Chg | +225.00% since 04/10/23 | +355.75% since 08/19/25 | -16.94% since 08/19/25 | ||
| Low | 0.2500 on 07/11/23 | 16.50 on 08/20/25 | 1.3900 on 02/06/26 | ||
| High | 1.4000 on 09/15/23 | 84.78 on 02/19/26 | 3.9500 on 10/16/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 70,121 | 225,677 | 55,194 | ||
| Shares Outstanding, K | 53,939 | 2,786 | 37,547 | ||
| Annual Sales | 0 | 11,540,000 | 52,300,000 | ||
| Annual Net Income | -35,040,000 | -10,580,000 | -78,060,000 | ||
| Last Quarter Sales | 0 | 400,000 | 8,660,000 | ||
| Last Quarter Net Income | -10,780,000 | -5,940,000 | -20,390,000 | ||
| 60-Month Beta | 1.32 | 1.36 | 0.50 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 08/14/23 | -2.13 on 11/20/25 | -0.55 on 11/11/25 | ||
| Latest Earnings Date | 11/13/23 | 05/05/26 | 03/16/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||